Liver Function Testing Requirements for Statin Therapy

Initial Assessment Before Starting Statins

• The American College of Cardiology recommends baseline measurement of hepatic transaminase levels before initiation of statin therapy to identify pre-existing liver conditions that might influence statin selection or dosing 1, 2, 3
• Baseline assessment helps identify patients with modest transaminase elevations (<3 times the upper limit of normal [ULN]) who are not contraindicated to start statin therapy but require careful monitoring 3

Monitoring After Starting Statins

• The American College of Cardiology and the FDA indicate that routine periodic monitoring of liver enzymes is NOT recommended after starting statin therapy if baseline levels are normal 1, 4
• The American College of Cardiology recommends that in patients treated with statins, routine measurements of transaminase levels are not useful 4, 5

When to Check Liver Function Tests During Statin Therapy

• Liver function tests should be measured if symptoms suggesting hepatotoxicity arise, including unusual fatigue or weakness, loss of appetite, abdominal pain, dark-colored urine, and yellowing of the skin or sclera (jaundice) 1, 2, 3, 4

Special Considerations

• For patients with chronic, stable liver disease, it is reasonable to use statins after obtaining baseline measurements and determining an appropriate monitoring schedule 4, 5
• The American College of Cardiology recommends using moderate-intensity statin therapy in patients with characteristics that may predispose them to statin-associated adverse effects, including impaired hepatic function 1

Clinical Evidence on Liver Safety

• The risk of serious liver injury with statin therapy is extremely rare and did not differ from placebo in clinical trials, with a study finding no significant hepatic adverse effects 6

Management of Abnormal Liver Tests

• If ALT elevations are less than 3 times ULN, continue statin therapy with follow-up testing, but if ALT elevations are greater than 3 times ULN, consult with healthcare provider to evaluate the net benefit of continuing statin therapy versus adjusting or discontinuing medication 6